ChemSpider 2D Image | Vilanterol trifenatate | C44H49Cl2NO7

Vilanterol trifenatate

  • Molecular FormulaC44H49Cl2NO7
  • Average mass774.768 Da
  • Monoisotopic mass773.288635 Da
  • ChemSpider ID24663012

  • defined stereocentres - 1 of 1 defined stereocentres

More details:

Featured data source
The Merck Index Online

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

40AHO2C6DG
503070-58-4 [RN]
Acide triphénylacétique - 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]éthoxy}hexyl)amino]-1-hydroxyéthyl}-2-(hydroxyméthyl)phénol (1:1) [French] [ACD/IUPAC Name]
Benzeneacetic acid, α,α-diphenyl-, compd. with (α1R)-α1-[[[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexyl]amino]methyl]-4-hydroxy-1,3-benzenedimethanol (1:1) [ACD/Index Name]
Triphenylacetic acid - 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol (1:1) [ACD/IUPAC Name]
Triphenylessigsäure --4-{(1R)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol (1:1) [German] [ACD/IUPAC Name]
Vilanterol trifenatate [USAN]
vilanterol trifenate
vilanterol triphenylacetate
(R)-4-(2-((6-(2-((2,6-DICHLOROBENZYL)OXY)ETHOXY)HEXYL)AMINO)-1-HYDROXYETHYL)-2-(HYDROXYMETHYL)PHENOL 2,2,2-TRIPHENYLACETATE
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

GW642444M [DBID]
GW 642444M [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Chemical Class:

      A triphenylacetate salt obtained by combining vilanterol with one equivalent of triphenylacetic acid. Used in combination with fluticasone furoate for treatment of bronchospasm associated with chroni c obstructive pulmonary disease. ChEBI https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:75040, CHEBI:75040

    • Bio Activity:

      Adrenergic Receptor MedChem Express HY-14300A
      GPCR/G protein MedChem Express HY-14300A
      GPCR/G protein; MedChem Express HY-14300A
      Vilanterol trifenatate (GW642444)is a novel, inhaled, long-acting ?(2) agonist with inherent 24-h activity under development as a once-daily combination therapy with an inhaled corticosteroid for COPD and asthma.; IC50 Value:; Target: ?(2) agonist; in vitro: Vilanterol displayed a subnanomolar affinity for the ?(2)-AR that was comparable with that of salmeterol but higher than olodaterol, formoterol, and indacaterol. MedChem Express HY-14300A

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site


Advertisement